Structure and function of human 17beta-hydroxysteroid dehydrogenases.

Prior research has shown that steroid hormones require enzymatic activation for nuclear receptor binding. It was already known that 17beta-hydroxysteroid dehydrogenases (17beta-HSDs) play a role in this process. However, the exact mechanisms of how these enzymes regulate hormone activity remained unclear. No prior work had resolved the full extent of human 17beta-HSD diversity. This gap motivated further investigation into the structural and functional properties of these enzymes. The field lacked a comprehensive analysis of their expression patterns and substrate preferences. Additionally, the potential for these enzymes to act as drug targets had not been fully explored. This uncertainty drove the need for a detailed review of the current literature.

The aim of this review is to synthesize current knowledge on the structure and function of human 17beta-HSDs. The study focuses on understanding how these enzymes regulate steroid hormone activity. It addresses the question of how different 17beta-HSDs contribute to hormone metabolism. The motivation comes from the enzymes' potential as therapeutic targets. The review also seeks to clarify their roles in various diseases. By compiling existing data, the authors aim to provide a framework for future research. The study emphasizes the need to distinguish between the 11 known human 17beta-HSDs. This work may help identify new approaches for drug development.

The authors conducted a literature review of 14 mammalian 17beta-HSDs. They analyzed gene expression patterns and enzyme localization. The study examined nucleotide cofactor preferences and substrate specificities. The review included data on subcellular localization and tissue distribution. The authors compared findings across different 17beta-HSD types. They also considered interactions with lipid metabolism pathways. The synthesis focused on functional differences and potential drug targets. The approach emphasized the importance of structural diversity among these enzymes.

The strongest finding is that 11 human 17beta-HSDs exist, each with distinct properties. These enzymes differ in cofactor preference and substrate specificity. Some prefer NAD(P)H over NAD(P)+. Others show broad substrate specificity. The review highlights their roles in converting inactive to active steroid forms. The enzymes are localized in various subcellular compartments. This localization may influence their regulatory functions. The findings suggest multiple 17beta-HSDs may act as drug targets.

The authors propose that 17beta-HSDs regulate steroid hormone activity through reversible oxidation. They suggest these enzymes may serve as pre-receptor control mechanisms. The review highlights the importance of structural diversity in enzyme function. The findings may support the development of drugs targeting these enzymes. The authors suggest that overlapping substrate specificities may explain interactions with lipid metabolism. They propose that these enzymes could be relevant in cancer and metabolic diseases. The study may guide future research on enzyme-specific inhibitors. The authors suggest further investigation into their roles in neurodegeneration and immunity.